GCCL Enters into Agreement with Frontage Laboratories to Boost Global Clinical Trial Capabilities
Wednesday, September 24, 2025
GCCL (Global Clinical Central Lab has entered into a strategic Memorandum of Understanding (MoU) with Frontage Laboratories.
The agreement, signed on 23 September, is aimed at strengthening both companies’ positions in the global clinical trial market.
The collaboration will focus on combining their complementary expertise and networks to improve competitiveness, particularly in the United States and Asia-Pacific regions. Planned areas of cooperation include joint clinical trial services, co-marketing initiatives, project support, and the development of new business opportunities.
By working together, the companies intend to enhance efficiency in the execution of clinical trial projects and provide differentiated services for clients worldwide.
The partnership is also expected to expand GCCL’s global reach while reinforcing Frontage’s clinical trial support system in the Asia-Pacific region.
Both organisations see the agreement as an opportunity to create growth, improve service delivery, and contribute to the advancement of the global clinical trial ecosystem.
Source: prnewswire.com
